Quick Takeaways
- BANK OF AMERICA CORP /DE/ filed SCHEDULE 13G/A for Ventyx Biosciences, Inc. Common Stock (VTYX).
- Disclosed ownership: 1.4%.
- Date of event: 31 Mar 2025.
BANK OF AMERICA CORP /DE/ - 31 Mar 2025 SCHEDULE 13G/A Report for Ventyx Biosciences, Inc. Common Stock (VTYX)
- Filing Manager
- BANK OF AMERICA CORP /DE/
- Reporting Manager
- BANK OF AMERICA CORP /DE/
- Symbol
- VTYX
- Shares outstanding
- 72,617,786 shares
- Disclosed Ownership
- 1,016,649 shares
- Ownership
- 1.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 13:10:00 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BANK OF AMERICA CORP /DE/ disclosed 1.4% ownership in Ventyx Biosciences, Inc. Common Stock (VTYX) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 15 May 2025, 13:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 1.4% | 1,016,649 | 0 | 1,016,649 | Andres Ortiz | Authorized Signatory |